Indian equities saw multiple stock-specific developments across pharma, banking, FMCG, and financials, with corporate disclosures shaping investor sentiment.
Dr Reddy’s Laboratories: Q3 Earnings Call Recording Available
Dr Reddy’s Laboratories Ltd informed exchanges that the audio recording of its earnings conference call for the quarter ended December 31, 2025, held on January 21, 2026, is now available on the company’s website. Investors and stakeholders can access the recording via the designated weblink to review management’s commentary on financial performance and outlook.
YES Bank Reappoints Executive Director
YES Bank announced the re-appointment of Dr. Rajan Pental as Executive Director for a six-month term from February 2, 2026 to July 31, 2026, subject to shareholder approval.
The reappointment has received RBI approval. Dr. Pental, who joined YES Bank in November 2015, brings over three decades of experience in financial services and currently oversees key retail, SME, and branch banking functions.
Nestlé India Gets Relief in Long-Pending Tax Dispute
Nestlé India received a favourable update on income tax litigation related to the disallowance of General Licensing fees for multiple years (FY96–98, FY99–01, FY04–08).
The Supreme Court of India dismissed the Income Tax department’s appeals as withdrawn, involving an aggregate amount of ₹101.21 crore. The matter had already been decided in Nestlé’s favour up to the Delhi High Court, strengthening the company’s legal position.
DCB Bank: Credit Ratings Reaffirmed by CRISIL
CRISIL Ratings reaffirmed DCB Bank’s credit ratings, citing stable financials and comfortable liquidity.
Key Rating Actions:
Tier II Bonds: CRISIL AA-/Stable (₹300 Cr & ₹400 Cr)
Short-term bank facilities: CRISIL A1+ (₹350 Cr)
Fixed Deposit Programme: CRISIL A1+
Certificate of Deposit Programme: CRISIL A1+, with limit enhanced to ₹2,000 Cr
Strengths Highlighted:
Strong capitalisation (Tier 1 CAR at 14%, overall CAR 16.4%)
Stable SME-focused loan book
Improving asset quality (GNPA at 2.9%)
Experienced management under MD & CEO Praveen Kutty
CRISIL noted that profitability remains moderate, impacted by operating costs and a relatively lower CASA ratio, though liquidity remains strong with an LCR of 123.22%.
Jai Mata Glass: Board Meet on Jan 29
Jai Mata Glass Limited will hold a board meeting on January 29, 2026, to approve standalone unaudited results for Q3 and 9M FY26. The board will also consider appointing a new Secretarial Auditor to fill a casual vacancy. The trading window will reopen 48 hours after results disclosure.
Persistent Systems Limited participated in a Non-Deal Roadshow on Jan 21, 2026, holding one-on-one meetings with WhiteOak Capital Management & HDFC Standard Life Insurance. During these interactions, the company reiterated information previously shared in the earnings call for the quarter & nine months ended Dec 31, 2025. No new financial details were disclosed.
Jaro Institute of Technol. Mgt. and Research Ltd's Board approved the Jaro Education Employees Stock Option Plan 2026, subject to shareholder approval & postal ballot. The scheme, to be implemented via Trust Route, allows for up to 10 Lakh options. Additionally, shareholders will vote on Ishan Baveja's re-appointment as Independent Director for a 5-year term from Feb 4, 2026. The company also approved the allotment of 20,050 equity shares upon exercise of options under the 2022 ESOP scheme.
